Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel Meeting on Device-Based Therapies for hypertension

Cardiovasc Revasc Med. 2019 Oct;20(10):891-896. doi: 10.1016/j.carrev.2019.07.016. Epub 2019 Jul 17.
No abstract available

Keywords: Food and Drug Administration; Hypertension; Renal denervation.

Publication types

  • Congress

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Autonomic Denervation / adverse effects
  • Autonomic Denervation / instrumentation*
  • Blood Pressure* / drug effects
  • Catheter Ablation / adverse effects
  • Catheter Ablation / instrumentation*
  • Device Approval*
  • Drug Resistance
  • Equipment Design
  • Equipment Safety
  • Humans
  • Hypertension / diagnosis
  • Hypertension / physiopathology
  • Hypertension / therapy*
  • Kidney / blood supply*
  • Patient Safety
  • Renal Artery / innervation*
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration*

Substances

  • Antihypertensive Agents